Literature DB >> 15156930

The importance and benefits of hepatitis A prevention in chronic liver disease patients.

Graham Cooksley1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15156930     DOI： 10.1111/j.1440-1746.2003.03394.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  3 in total

1.  Hepatitis B virus and hepatitis C virus services offered by substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Donald Calsyn; Don Alderson; Kathlene Tracy; Patrick McAuliffe; Cheryl Smith; John Rotrosen
Journal:  J Subst Abuse Treat       Date:  2011-10-27

2.  Anti-hepatitis A seroprevalence among chronic viral hepatitis patients in Kelantan, Malaysia.

Authors:  Fazlina Ahmad; Nor Aizal Che Hamzah; Nazri Mustaffa; Siew Hua Gan
Journal:  World J Gastroenterol       Date:  2011-09-28       Impact factor: 5.742

Review 3.  Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea.

Authors:  Hyun Joo Song; Tae Hun Kim; Ji Hyun Song; Hee Jung Oh; Kum Hei Ryu; Hye Jung Yeom; Seong-Eun Kim; Hye-Kyung Jung; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Il-Hwan Moon; Kyu Won Chung
Journal:  J Korean Med Sci       Date:  2007-04       Impact factor: 2.153
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.